EX-FILING FEES 7 e6429_ex107.htm EXHIBIT 107

 

 

Exhibit 107

 

Calculation of Filing Fee Table

 

Form S-1

 

(Form Type)

 

VIRPAX PHARMACEUTICALS, INC..

 

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

  

  Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit (1) Maximum Aggregate Offering Price (1)(2)  Fee Rate Amount of Registration Fee(3)
Newly Registered Securities
Fees to Be Paid Equity Units, consisting of:            
  Equity Common stock, $0.001 par value per share  457(o)  —  —  $ 5,000,000  $0.00015310  $765.50
  Equity Pre- Funded Warrants to purchase shares of common stock(4)  457(o)  —  —  —  —  —
  Equity Common stock issuable upon exercise of the Pre- Funded Warrants  457(i)  —  —    —  —
  Total Offering Amounts   $ 5,000,000   $765.50
  Total Fees Previously Paid      
  Total Fee Offsets      
  Net Fee Due       $765.50

 

(1)Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).
(2)Pursuant to Rule 416(a) under the Securities Act, there are also being registered an indeterminate number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends, or similar transactions.
(3)The proposed maximum aggregate offering price of the Common Stock proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the aggregate offering price of the Pre-Funded Warrants offered and sold in the offering (plus the aggregate exercise price of the Common Stock issuable upon exercise of the Pre-Funded Warrant).